CBR1 anticorps (AA 176-268) (FITC)
Aperçu rapide pour CBR1 anticorps (AA 176-268) (FITC) (ABIN7146743)
Antigène
Voir toutes CBR1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 176-268
-
Fonction
- CBR1 Antibody, FITC conjugated
-
Purification
- Protein G purified
-
Pureté
- >95 %
-
Immunogène
- Recombinant Human Carbonyl reductase [NADPH] 1 protein (176-268AA)
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CBR1 (Carbonyl Reductase 1 (CBR1))
-
Autre désignation
- CBR1
-
Sujet
-
Background: NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2-alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S-nitrosoglutathione.
Aliases: 15 hydroxyprostaglandin dehydrogenase [NADP+] antibody, 15-hydroxyprostaglandin dehydrogenase [NADP+] antibody, Carbonyl reductase [NADPH] 1 antibody, Carbonyl Reductase 1 antibody, CBR 1 antibody, CBR1 antibody, CBR1_HUMAN antibody, CRN antibody, NADPH dependent carbonyl reductase 1 antibody, NADPH-dependent carbonyl reductase 1 antibody, Prostaglandin 9 ketoreductase antibody, Prostaglandin 9-ketoreductase antibody, Prostaglandin E(2) 9 reductase antibody, Prostaglandin-E(2) 9-reductase antibody, SDR21C1 antibody
-
UniProt
- P16152
Antigène
-